The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Incivek™ (telaprevir) and Hepatitis C

At what point would one know the Incivek™ combination therapy is not working?

According to the prescribing information provided by Vertex, treatment with Incivek™ should be discontinued if HCV-RNA results at week 4 or week 12 show levels greater than or equal to 1000 IU/mL. If HCV-RNA levels are confirmed detectable at week 24 of therapy, peginterferon alfa and ribavirin should be discontinued.

Last Updated: July 2014

Vertex Pharmaceuticals "Highlights of Prescribing Information - Incivek™" http://pi.vrtx.com/files/uspi_telaprevir.pdf. Retrieved May 23, 2011.

Vertex Pharmaceuticals "Medication Guide - Incivek™" http://pi.vrtx.com/files/usmedguide_telaprevir.pdf. Retrieved May 23, 2011.

Vertex Pharmaceuticals "For Patients - Helping People Get Incivek™ (telaprevir) tablets" http://www.vrtx.com/patients.html. Retrieved May 23, 2011.